Please login to the form below

Not currently logged in
Email:
Password:

Peru

This page shows the latest Peru news and features for those working in and with pharma, biotech and healthcare.

CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval

CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval

Another phase 2a in Peru and Panama has also completed recruitment with 674 participants.

Latest news

More from news
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • Safe from harm? Safe from harm?

    Across the world, attitudes towards healthcare decision-making vary substantially. Peru (75%), Bolivia (75%), Egypt (71%) and Chile (66%) are the countries where physicians are most likely to make treatment decisions.

  • Current development and marketing of biosimilar monoclonal antibodies in Latin America Current development and marketing of biosimilar monoclonal antibodies in Latin America

    Market. Marketed in Chile, Ecuador, Peru and Paraguay. (1). CF Recalcine (Chile). ... 5) Partnership with Human Bioscience established on July 2012 for commercialization in Colombia, Venezuela, Ecuador and Peru.}.

  • Unfolding the biosimilar landscape in Latin America Unfolding the biosimilar landscape in Latin America

    Countries like Colombia, which is on the cusp of publishing its guidelines, Venezuela, Peru or Ecuador have yet to reach a similar development status, while some smaller countries have yet to ... In Latin America, this includes countries like Brazil,

  • Positive prospects for pharma in Latin America Positive prospects for pharma in Latin America

    Espicom Business Intelligence predicts that the region's eight major markets — Brazil, Mexico, Argentina, Chile, Colombia, Cuba, Peru and Venezuela — will represent a retail value of $80bn in 2013, up from ... In Mexico, Venezuela and Peru, public

  • Interview with Roch Doliveux, UCB Interview with Roch Doliveux, UCB

    He joined the pharmaceutical industry early in his career, first at Ciba-Geigy (now Novartis) in Switzerland, Peru and France.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics